GlassScriptPhysician profile
Raj P Terkonda
NPI 1639176803
$35,799.12
in general payments reported to CMS, 2019-2025
44 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 88% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $727 · 2021: $902 · 2022: $4,000 · 2023: $27K · 2024: $1,485 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $6,245 · Travel and Lodging: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,750.00 |
| Food and Beverage | $6,245.49 |
| Travel and Lodging | $1,018.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $29,611.68 | 2020-2025 | |
| Inspire Medical Systems, INC. | $2,148.20 | 2020-2024 | Inspire |
| Stryker Corporation | $666.15 | 2019-2024 | Clarifix Cryotherapy Device, Na |
| Zoll Respicardia, INC. | $301.18 | 2020-2023 | Remede System |
| Musculoskeletal Transplant Foundation INC. | $237.40 | 2022-2024 | |
| Glaxosmithkline, LLC. | $218.39 | 2021-2025 | Nucala |
| Itamar Medical INC | $157.68 | 2022-2025 | Watchpatone |
| Pharming Healthcare, INC. | $156.24 | 2025 | Ruconest |
| Idorsia Pharmaceuticals US INC | $151.69 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $147.65 | 2023-2025 | Takhzyro |
| Lilly USA, LLC | $146.67 | 2025 | Zepbound, Mounjaro |
| Depuy Synthes Sales INC. | $135.29 | 2024 | Matrixmidface |
| Acclarent, INC | $128.90 | 2020-2022 | |
| Abbvie INC. | $128.49 | 2023-2024 | Botox, Dalvance |
| 3b Medical, INC. | $119.92 | 2023 | Luna |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Terkonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.